Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.
Kang S, Yoo C, Lee SH, Oh D, Song TJ, Lee SS, Jeong JH, Park DH, Seo DW, Park JH, Hwang DW, Song KB, Lee JH, Lee W, Kwak BJ, Hong S, Chang HM, Ryoo BY, Kim KP, Kim SC.
Kang S, et al.
Ther Adv Med Oncol. 2022 May 9;14:17588359221097190. doi: 10.1177/17588359221097190. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 35571606
Free PMC article.